Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Mibefradil and amlodipine compared in patients with exercise-induced and silent ischemia

Oct. 30, 1997

Effects of NO donor ITF-1129 on blood flow/hemodynamics during myocardial ischemia

Oct. 29, 1997

Endothelin antagonists described by Bristol-Myers Squibb

Oct. 29, 1997

Alexion reports phase I/II and IIa results for C5 inhibitor

Oct. 28, 1997

Flamel Technologies reports clinical results on Asacard

Oct. 27, 1997

SmithKline Beecham to copromote Teveten with HMR

Oct. 23, 1997

Novel angiotensin II antagonists for hypertension/CHF

Oct. 23, 1997

Abbott describes new endothelin antagonists

Oct. 23, 1997

Fujirebio cardiovascular agent advances to phase II

Oct. 23, 1997

Biovail and Technilab Pharma sign marketing agreement

Oct. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...